Bio


Shehla Admani, M.D. is Clinical Assistant Professor of Dermatology. Dr. Admani completed her dermatology residency at the University California, San Diego where she served as chief resident during her final year. She is board certified in dermatology and pediatric dermatology. Dr. Admani’s academic interests include pediatric dermatology, vulvar dermatology, skin cancer and dermatologic surgery.

Clinical Focus


  • Dermatology

Academic Appointments


Professional Education


  • Board Certification: American Board of Dermatology, Pediatric Dermatology (2018)
  • Fellowship: Stanford University Pediatric Dermatology (2018) CA
  • Board Certification: American Board of Dermatology, Dermatology (2017)
  • Residency: UCSD Dermatology Residency (2017) CA
  • Internship: University of California Irvine Dept of Internal Medicine (2012) CA
  • Medical Education: University of California at Irvine School of Medicine Registrar (2011) CA

All Publications


  • Lice Infestations in the Pediatric Population JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION Vassantachart, J. M., Florentino, A., Admani, S. 2021; 13 (5): 284-287
  • COVID-19 Pandemic Leading to the Accelerated Development of a Virtual Health Model for Isotretinoin JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION Kane, S., Admani, S. 2021; 13 (1): 54–57
  • Aquagenic pruritus in an adolescent effectively managed with beta-alanine supplementation. Pediatric dermatology Friedlander, M. S., Admani, S. 2020

    Abstract

    Aquagenic pruritus is a rare debilitating condition, which can be idiopathic, iatrogenic, or associated with systemic disease. In idiopathic cases, treatment can be challenging as options are limited and of variable efficacy. Here, we report the case of a teenage boy with refractory idiopathic aquagenic pruritus effectively managed with administration of beta-alanine supplementation, a treatment gaining traction in lay media but not yet reported in the medical literature. This report adds to the limited options published for treatment of idiopathic aquagenic pruritus in pediatric patients.

    View details for DOI 10.1111/pde.14440

    View details for PubMedID 33170524

  • COVID-19 Pandemic Leading to the Accelerated Development of a Virtual Health Model for Isotretinoin. Journal of the Dermatology Nurses' Association Kane, S., Admani, S. 2020; 13 (1): 54-57

    Abstract

    Isotretinoin is a highly efficacious medication for the treatment of acne vulgaris; however, its prescription is subject to the strict requirements of the iPLEDGE restricted distribution program. These requirements have placed significant financial, time, and logistical burdens on patients taking the medication. The stay-at-home ordinances enacted by many states during the 2019 novel coronavirus (COVID-19) global pandemic have accelerated previous trends toward utilization of telehealth and decreased laboratory monitoring in the care of patients on isotretinoin. Recent changes to the iPLEDGE program allowing use of at-home pregnancy tests to meet monthly pregnancy test requirements during the pandemic have increased availability of testing options for patients of child-bearing potential on isotretinoin. The change to use of at-home pregnancy test monitoring as well as long-term trends toward increasing access to isotretinoin through the use of telehealth are discussed.

    View details for DOI 10.1097/JDN.0000000000000595

    View details for PubMedID 34191969

    View details for PubMedCentralID PMC7813218

  • Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child. JAMA dermatology Lekwuttikarn, R., Lim, Y. H., Admani, S., Choate, K. A., Teng, J. M. 2018

    View details for PubMedID 30566190

  • Wash-Line Dermatitis: A Diagnostic Clue. The Journal of clinical and aesthetic dermatology Jacob, S. E., Admani, S. 2018; 11 (10): 12

    View details for PubMedID 30519373

  • DYE ALLERGY ASSOCIATED WITH CONTACT WITH HELLO KITTY LUNCH BOX. The Journal of clinical and aesthetic dermatology Jacob, S. E., Admani, S. 2018; 11 (9): 12

    View details for PubMedID 30319725

  • Response Letter to "Contact Dermatitis Associated with Alopecia and Hyperpigmentation". Pediatric dermatology Goldenberg, A. n., Admani, S. n., Jacob, S. E. 2017; 34 (5): 626

    View details for PubMedID 28884898